 | • レポートコード：MRC23Q38389 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の再生注射市場について調査・分析し、世界の再生注射市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（PLLAフィラー、ガーリーフィラー、その他）、用途別セグメント分析（公立病院、美容医療機関）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Anteco Pharma、ELASTEM、Galderma、GANA R&D、Regen Biotech、IMEIK、Hanggai Biological、Huadong Medicine、Changchun SinoBiomaterials、Zhejiang Wedu Medicalなどが含まれています。世界の再生注射市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、再生注射市場規模を推定する際に考慮しました。本レポートは、再生注射の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、再生注射に関するビジネス上の意思決定に役立てることを目的としています。 ・再生注射市場の概要 - 製品の定義 - 再生注射のタイプ別セグメント - 世界の再生注射市場規模：タイプ別分析（PLLAフィラー、ガーリーフィラー、その他） - 再生注射の用途別セグメント - 世界の再生注射市場規模：用途別分析（公立病院、美容医療機関） - 世界の再生注射市場規模予測（2018年-2029年） - 再生注射の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 再生注射市場の競争状況およびトレンド ・再生注射の地域別市場規模 - 北米の再生注射市場規模（2018年-2029年） - アメリカの再生注射市場規模（2018年-2029年） - ヨーロッパの再生注射市場規模（2018年-2029年） - アジア太平洋の再生注射市場規模（2018年-2029年） - 中国の再生注射市場規模（2018年-2029年） - 日本の再生注射市場規模（2018年-2029年） - 韓国の再生注射市場規模（2018年-2029年） - インドの再生注射市場規模（2018年-2029年） - オーストラリアの再生注射市場規模（2018年-2029年） - 中南米の再生注射市場規模（2018年-2029年） - 中東・アフリカの再生注射市場規模（2018年-2029年） ・タイプ別セグメント：PLLAフィラー、ガーリーフィラー、その他 - 世界の再生注射のタイプ別販売量（2018年-2023年） - 世界の再生注射のタイプ別売上（2018年-2023年） - 世界の再生注射のタイプ別価格 ・用途別セグメント：公立病院、美容医療機関 - 世界の再生注射の用途別販売量（2018年-2023年） - 世界の再生注射の用途別売上（2018年-2023年） - 世界の再生注射の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Anteco Pharma、ELASTEM、Galderma、GANA R&D、Regen Biotech、IMEIK、Hanggai Biological、Huadong Medicine、Changchun SinoBiomaterials、Zhejiang Wedu Medical ・産業チェーンと販売チャネルの分析 - 再生注射産業チェーン分析 - 再生注射の主要原材料 - 再生注射の販売チャネル - 再生注射のディストリビューター - 再生注射の主要顧客 ・再生注射市場ダイナミクス - 再生注射の業界動向 - 再生注射市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Regeneration Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Regeneration Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Regeneration Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Regeneration Injection include Anteco Pharma, ELASTEM, Galderma, GANA R&D, Regen Biotech, IMEIK, Hanggai Biological, Huadong Medicine and Changchun SinoBiomaterials, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Regeneration Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Regeneration Injection.
The Regeneration Injection market size, estimations, and forecasts are provided in terms of sales volume (K L) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Regeneration Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Regeneration Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Anteco Pharma
ELASTEM
Galderma
GANA R&D
Regen Biotech
IMEIK
Hanggai Biological
Huadong Medicine
Changchun SinoBiomaterials
Zhejiang Wedu Medical
Segment by Type
PLLA Filler
Girly Filler
Others
Segment by Application
Public Hospital
Medical Beauty Institution
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Regeneration Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Regeneration Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Regeneration Injection Market Overview
1.1 Product Overview and Scope of Regeneration Injection
1.2 Regeneration Injection Segment by Type
1.2.1 Global Regeneration Injection Market Value Comparison by Type (2023-2029)
1.2.2 PLLA Filler
1.2.3 Girly Filler
1.2.4 Others
1.3 Regeneration Injection Segment by Application
1.3.1 Global Regeneration Injection Market Value by Application: (2023-2029)
1.3.2 Public Hospital
1.3.3 Medical Beauty Institution
1.4 Global Regeneration Injection Market Size Estimates and Forecasts
1.4.1 Global Regeneration Injection Revenue 2018-2029
1.4.2 Global Regeneration Injection Sales 2018-2029
1.4.3 Global Regeneration Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Regeneration Injection Market Competition by Manufacturers
2.1 Global Regeneration Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Regeneration Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Regeneration Injection Average Price by Manufacturers (2018-2023)
2.4 Global Regeneration Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Regeneration Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Regeneration Injection, Product Type & Application
2.7 Regeneration Injection Market Competitive Situation and Trends
2.7.1 Regeneration Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Regeneration Injection Players Market Share by Revenue
2.7.3 Global Regeneration Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Regeneration Injection Retrospective Market Scenario by Region
3.1 Global Regeneration Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Regeneration Injection Global Regeneration Injection Sales by Region: 2018-2029
3.2.1 Global Regeneration Injection Sales by Region: 2018-2023
3.2.2 Global Regeneration Injection Sales by Region: 2024-2029
3.3 Global Regeneration Injection Global Regeneration Injection Revenue by Region: 2018-2029
3.3.1 Global Regeneration Injection Revenue by Region: 2018-2023
3.3.2 Global Regeneration Injection Revenue by Region: 2024-2029
3.4 North America Regeneration Injection Market Facts & Figures by Country
3.4.1 North America Regeneration Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Regeneration Injection Sales by Country (2018-2029)
3.4.3 North America Regeneration Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Regeneration Injection Market Facts & Figures by Country
3.5.1 Europe Regeneration Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Regeneration Injection Sales by Country (2018-2029)
3.5.3 Europe Regeneration Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Regeneration Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Regeneration Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Regeneration Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Regeneration Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Regeneration Injection Market Facts & Figures by Country
3.7.1 Latin America Regeneration Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Regeneration Injection Sales by Country (2018-2029)
3.7.3 Latin America Regeneration Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Regeneration Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Regeneration Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Regeneration Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Regeneration Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Regeneration Injection Sales by Type (2018-2029)
4.1.1 Global Regeneration Injection Sales by Type (2018-2023)
4.1.2 Global Regeneration Injection Sales by Type (2024-2029)
4.1.3 Global Regeneration Injection Sales Market Share by Type (2018-2029)
4.2 Global Regeneration Injection Revenue by Type (2018-2029)
4.2.1 Global Regeneration Injection Revenue by Type (2018-2023)
4.2.2 Global Regeneration Injection Revenue by Type (2024-2029)
4.2.3 Global Regeneration Injection Revenue Market Share by Type (2018-2029)
4.3 Global Regeneration Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Regeneration Injection Sales by Application (2018-2029)
5.1.1 Global Regeneration Injection Sales by Application (2018-2023)
5.1.2 Global Regeneration Injection Sales by Application (2024-2029)
5.1.3 Global Regeneration Injection Sales Market Share by Application (2018-2029)
5.2 Global Regeneration Injection Revenue by Application (2018-2029)
5.2.1 Global Regeneration Injection Revenue by Application (2018-2023)
5.2.2 Global Regeneration Injection Revenue by Application (2024-2029)
5.2.3 Global Regeneration Injection Revenue Market Share by Application (2018-2029)
5.3 Global Regeneration Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Anteco Pharma
6.1.1 Anteco Pharma Corporation Information
6.1.2 Anteco Pharma Description and Business Overview
6.1.3 Anteco Pharma Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Anteco Pharma Regeneration Injection Product Portfolio
6.1.5 Anteco Pharma Recent Developments/Updates
6.2 ELASTEM
6.2.1 ELASTEM Corporation Information
6.2.2 ELASTEM Description and Business Overview
6.2.3 ELASTEM Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 ELASTEM Regeneration Injection Product Portfolio
6.2.5 ELASTEM Recent Developments/Updates
6.3 Galderma
6.3.1 Galderma Corporation Information
6.3.2 Galderma Description and Business Overview
6.3.3 Galderma Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Galderma Regeneration Injection Product Portfolio
6.3.5 Galderma Recent Developments/Updates
6.4 GANA R&D
6.4.1 GANA R&D Corporation Information
6.4.2 GANA R&D Description and Business Overview
6.4.3 GANA R&D Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GANA R&D Regeneration Injection Product Portfolio
6.4.5 GANA R&D Recent Developments/Updates
6.5 Regen Biotech
6.5.1 Regen Biotech Corporation Information
6.5.2 Regen Biotech Description and Business Overview
6.5.3 Regen Biotech Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Regen Biotech Regeneration Injection Product Portfolio
6.5.5 Regen Biotech Recent Developments/Updates
6.6 IMEIK
6.6.1 IMEIK Corporation Information
6.6.2 IMEIK Description and Business Overview
6.6.3 IMEIK Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 IMEIK Regeneration Injection Product Portfolio
6.6.5 IMEIK Recent Developments/Updates
6.7 Hanggai Biological
6.6.1 Hanggai Biological Corporation Information
6.6.2 Hanggai Biological Description and Business Overview
6.6.3 Hanggai Biological Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hanggai Biological Regeneration Injection Product Portfolio
6.7.5 Hanggai Biological Recent Developments/Updates
6.8 Huadong Medicine
6.8.1 Huadong Medicine Corporation Information
6.8.2 Huadong Medicine Description and Business Overview
6.8.3 Huadong Medicine Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Huadong Medicine Regeneration Injection Product Portfolio
6.8.5 Huadong Medicine Recent Developments/Updates
6.9 Changchun SinoBiomaterials
6.9.1 Changchun SinoBiomaterials Corporation Information
6.9.2 Changchun SinoBiomaterials Description and Business Overview
6.9.3 Changchun SinoBiomaterials Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Changchun SinoBiomaterials Regeneration Injection Product Portfolio
6.9.5 Changchun SinoBiomaterials Recent Developments/Updates
6.10 Zhejiang Wedu Medical
6.10.1 Zhejiang Wedu Medical Corporation Information
6.10.2 Zhejiang Wedu Medical Description and Business Overview
6.10.3 Zhejiang Wedu Medical Regeneration Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Zhejiang Wedu Medical Regeneration Injection Product Portfolio
6.10.5 Zhejiang Wedu Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Regeneration Injection Industry Chain Analysis
7.2 Regeneration Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Regeneration Injection Production Mode & Process
7.4 Regeneration Injection Sales and Marketing
7.4.1 Regeneration Injection Sales Channels
7.4.2 Regeneration Injection Distributors
7.5 Regeneration Injection Customers
8 Regeneration Injection Market Dynamics
8.1 Regeneration Injection Industry Trends
8.2 Regeneration Injection Market Drivers
8.3 Regeneration Injection Market Challenges
8.4 Regeneration Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer